Whole-Body Positron Emission Tomography with 18F-Fluorodeoxyglucose/Magnetic Resonance Imaging as a Screening Tool for the Detection of Malignant Transformation in Individuals with Neurofibromatosis Type 1
L. Fertitta, A. Jannic, O. Zehou, Christina Bergqvist, S. Ferkal, Sabine Moryousef, Lionel Lerman, Sebastien Mulé, Alain Luciani, Blanche Bapst, Khaled Ezzedine, Nicolás Ortonne, Emmanuel Itti, P. Wolkenstein
Topics & Concepts
Positron emission tomographyMagnetic resonance imagingNeurofibromatosisMedicineNuclear medicineFluorodeoxyglucoseTransformation (genetics)Positron emissionPositronRadiologyComputed tomographyNuclear magnetic resonancePhysicsChemistryNuclear physicsGeneElectronBiochemistryNeurofibromatosis and Schwannoma CasesMeningioma and schwannoma managementNeuroblastoma Research and Treatments